FDA Releases Alexion Pharmaceuticals Inc. Response to 483 Report

Published: May 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

In a rare move, the FDA has publically released Alexion Pharmaceuticals’ response to a Form 483 following inspection of its US site and the discovery of microbial contamination.

Help employers find you! Check out all the jobs and post your resume.

Back to news